136 related articles for article (PubMed ID: 37710256)
1. Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model.
Di W; Xu H; Ling C; Xue T
Thromb J; 2023 Sep; 21(1):95. PubMed ID: 37710256
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
3. Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.
Ji Y; Qin Y; Tan Q; Qiu Y; Han S; Qi X
BMC Biotechnol; 2024 May; 24(1):30. PubMed ID: 38720310
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of Coagulation and Fibrinolysis Markers for Predicting Postoperative Venous Thromboembolism in Total Joint Arthroplasty Patients.
Cheng Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Zhang W; Wu J
Clin Appl Thromb Hemost; 2019; 25():1076029619877458. PubMed ID: 31608652
[TBL] [Abstract][Full Text] [Related]
5. Derivation, validation and assessment of a novel nomogram-based risk assessment model for venous thromboembolism in hospitalized patients with lung cancer: A retrospective case control study.
Li H; Tian Y; Niu H; He L; Cao G; Zhang C; Kaiweisierkezi K; Luo Q
Front Oncol; 2022; 12():988287. PubMed ID: 36300098
[TBL] [Abstract][Full Text] [Related]
6. Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study.
Wang L; Zhong J; Xiao D; Huang W; Zheng Z; Jiang Y
Ann Transl Med; 2022 Dec; 10(23):1273. PubMed ID: 36618792
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients.
Akasaka-Kihara F; Sueta D; Ishii M; Maki Y; Hirakawa K; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Hanatani S; Kanazawa H; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Kaikita K; Matsushita K; Matsuoka M; Usuku K; Tsujita K
JACC Asia; 2021 Sep; 1(2):259-270. PubMed ID: 36338156
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.
Yang Y; Feng G; Yan J; Wu L; Wang F; Ding D; Wang H; Jin Q
Clin Appl Thromb Hemost; 2022; 28():10760296221097383. PubMed ID: 35535394
[TBL] [Abstract][Full Text] [Related]
9. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
[TBL] [Abstract][Full Text] [Related]
10. The Diagnostic Value of the Systemic Immune-Inflammation Index for Venous Thromboembolism in Lung Cancer Patients: A Retrospective Study.
Zhang L; Liu X; Yang R; Yang Y; Chen X
Mediators Inflamm; 2022; 2022():9215311. PubMed ID: 36046761
[TBL] [Abstract][Full Text] [Related]
11. Clinical study on the feasibility of new thrombus markers in predicting massive cerebral infarction.
Zhao X; Yang S; Lei R; Duan Q; Li J; Meng J; Sun L
Front Neurol; 2022; 13():942887. PubMed ID: 36761916
[TBL] [Abstract][Full Text] [Related]
12. [Recent advances in the application of TAT, TM, t-PAIC and PIC in thromboembolism].
Li YJ; Zhang Q; Wang HC
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1693-1703. PubMed ID: 37859391
[TBL] [Abstract][Full Text] [Related]
13. Value of novel thrombotic markers for predicting occurrence of the malignant cerebral artery infarction: a prospective clinical study.
Zhao X; Yang S; Lei R; Liu Y; Duan Q; Li J; Sun L
Front Neurol; 2023; 14():1238742. PubMed ID: 38099069
[TBL] [Abstract][Full Text] [Related]
14. Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data.
Tsubata Y; Kawakado K; Hamai K; Furuya N; Yokoyama T; Saito R; Nakamura A; Masuda T; Hamaguchi M; Kuyama S; Honda R; Senoo T; Nakanishi M; Hotta T; Yamasaki M; Ishikawa N; Fujitaka K; Kubota T; Kobayashi K; Isobe T
Int J Clin Oncol; 2023 Jan; 28(1):69-78. PubMed ID: 36357710
[TBL] [Abstract][Full Text] [Related]
15. [Value of Coagulation and Fibrinolysis Biomarker in Lung Cancer Patients with Thromboembolism].
Fu Y; Liu Y; Jin Y; Jiang H
Zhongguo Fei Ai Za Zhi; 2018 Aug; 21(8):583-587. PubMed ID: 30172264
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of thrombin-antithrombin III complex and tissue plasminogen activator-inhibitor complex biomarkers in assessing the severity of early-stage acute pancreatitis.
Liao C; Liu G; Li L; Wang J; Ouyang L; Lei P; Fan S
J Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38822643
[TBL] [Abstract][Full Text] [Related]
17. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer.
Li S; Gao P; Qiu J; He X; Mao Y
J Thromb Thrombolysis; 2021 Oct; 52(3):898-903. PubMed ID: 33599857
[TBL] [Abstract][Full Text] [Related]
18. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
[No Abstract] [Full Text] [Related]
19. Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients.
Hiraide M; Shiga T; Minowa Y; Nakano Y; Yoshioka H; Suzuki K; Yasuda C; Takahashi H; Hama T
J Cardiol; 2020 Jan; 75(1):110-114. PubMed ID: 31416782
[TBL] [Abstract][Full Text] [Related]
20. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
Castellón Rubio VE; Segura PP; Muñoz A; Farré AL; Ruiz LC; Lorente JA
Thromb Res; 2020 Dec; 196():349-354. PubMed ID: 32977135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
